Herzliya-based ElMindA has trademarked their non-invasive BNA (brain network activation) device that maps network activation points in the brain. It produces a three-dimensional image of nerve cell connectivity and synchronization and can potentially pinpoint the stage of many diseases and predict which patients will respond to which drugs.
http://www.israel21c.org/health/non-invasive-tool-identifies-alzheimers-depression-and-adhd/